CMR continues rapid expansion


Cambridge, UK, [20 February 2017]: Cambridge Medical Robotics Ltd, the UK’s leading surgical robotics company, today announces that it has acquired an additional 6,500 sq. ft. of office and development space to keep pace with its rapid expansion. The additional space extends the company’s facilities in Cambridge to over 14,000 sq. ft.  

In December, the company revealed its Versius universal robotic surgery system designed to perform minimally invasive upper GI, gynaecological, colorectal and renal surgery and is now rapidly progressing towards manufacturing scale up and market introduction. CMR’s mission is to make surgical robotics commonplace in every hospital by providing a cost-effective, flexible, next-generation solution capable of carrying out 90% of minimal access procedures.

Martin Frost, CEO, commented: “We have built a world-class surgical robotics team here in Cambridge and, as we get closer to turning our vision into reality, our desire to recruit more top-flight people to join our team only increases. Our team is passionate about developing a next-generation system that will significantly improve the lives of millions of people undergoing surgery each year around the world.”

In just three years the company has grown to over 70 people and, whilst expansion continues at a pace, the company maintains a strong culture of ambition, creativity and teamwork.





Cambridge Medical Robotics
Patrick Pordage
Head of Marketing
Tel: +44 (0) 1223 755 388


About Cambridge Medical Robotics Limited

Cambridge Medical Robotics is developing a next-generation robotic system for universal keyhole surgery. The Versius system comprises a surgeon console, modular light-weight robotic arms and a range of wristed 5 mm instruments. The system uses state-of-the-art 3D high-definition imagery, significantly enhanced flexibility, and incorporates haptic feedback to provide surgeons with life-like sensitivity.

CMR aims to expand the surgical robotics market by significantly increasing the volume and range of supported procedures, making keyhole surgery universally accessible and affordable.

Versius overcomes obstacles to widespread adoption of robotic minimal access surgery, namely robot size, instrument size, versatility, port placement, cost and ease of use, allowing the system to be highly utilised and ultimately cost-comparable to manual laparoscopic surgery.

Global annual revenues for robotic-assisted keyhole surgery are presently approximately $3.2 billion and are anticipated to reach $20 billion by 2021 (‘Research and Markets’).

The Company was formed in 2014 and has its headquarters in Cambridge, United Kingdom.

For further information please visit: